Oculus intends to conduct $4.7 million at-the-market equity offering

Agent MLV & Co. will sell the company’s common stock through offering

By Devika Patel

Knoxville, Tenn., Dec. 16 – Oculus Innovative Sciences, Inc. negotiated a $4.7 million at-the-market equity offering with agent MLV & Co. LLC, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.

MLV will receive a 3% commission.

Proceeds will be used for working capital and general corporate purposes.

Oculus is a specialty pharmaceutical company based in Petaluma, Calif., that develops and markets solutions for the treatment of dermatological conditions and tissue care

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.